Abstract
The cause of Crohn’s disease (CD) has remained an enigma for many years. However, in 1913 Dalziel proposed a mycobacterial origin for CD, comparing its1 likeness to Johne’s disease—an ileocolonic inflammation of ruminants caused by Mycobacterium paratuberculosis. Recently very slow growing, fastidious mycobacteria have been isolated from CD cases in various parts of the world. These isolates were found identical to one another and to M. paratuberculosis by random gene sequencing and restriction polymorphism of the ribosomal 5S gene. Immunologic studies and specific stains, to show the organism in infected tissues, have not been helpful. Preliminary studies with antimycobacterial antibiotics are encouraging, however. Although further studies need to be performed, atypical mycobacteria still remain a potential pathogenic organism for CD.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abrams, J, and Holden, W. (1964) ‘Tuberculosis of the gastrointestinal tract’. Archives of Surgery 89, 282–293.
Allan, R.N., Pease, P. and Ibbotson, J.P. (1986) ‘Clustering of Crohn’s disease in a Cotswold village’. Quarterly Journal of Medicine 59, 473–478.
Beaman, B.L. and Scates, S.M. (1981) ‘Role of L-forms of Nocardia caviae in the development of chronic mycetomas in normal and immunodeficient murine models’. Infection and Immunity 33, 893–907.
Bennett, R., Rubin, P. and Present, D. (1988) ‘Inflammatory bowel disease in husbands and wives. Frequency of IBD in 35 offspring of 19 couples’. Gastroenterology 94, A611.
Binder, H., Spiro, H. and Thayer, W.R. (1966) ‘Delayed hypersensitivity in regional enteritis and ulcerative colitis’. American Journal of Digestive Diseases 11, 572–574.
Bird, A. and Britton, S. (1974) ‘No evidence for decreased lymphocyte reactivity in Crohn’s disease’. Gastroenterology 67, 926–932.
Burnham, W.R., Lennard-Jones, J.E., Stanford, J.L. and Bird, R.G. (1978) ‘Mycobacteria as a possible cause of inflammatory bowel disease’. Lancet 2, 693–696.
Chiodini, R.J. (1989) ‘Crohn’s disease and the mycobacterioses. A review and comparison of two disease entities’. Clinical Microbiology Reviews 2, 90–117.
Chiodini, R.J. (1988) ‘Identification of mycobacteria from Crohn’s disease by restriction polymorphism of the 5S ribosomal DNA genes’. In R.P. MacDermott (ed.), Inflammatory Bowel Disease. Current Status and Future Approach, Elsevier Science, New York, pp. 509–514.
Chiodini, R.J. VanKruiningen, H.J. and Merkal, R. (1984) ‘Ruminant paratuberculosis (Johne’s disease): the current status and future prospects’. Cornell Veterinarian 74, 218–262.
Chiodini, R.J., VanKruiningen, H.J., Merkal, R, Thayer, W.R. and Coutu, J.A. (1984) ‘Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn’s disease’. J. Clinical Microbiology 20, 966–971.
Chiodini, R.J., VanKruiningen, H.J., Thayer, W.R. and Coutu, J.A. (1986) ‘Spheroplastic phase of mycobacteria isolated from patients with Crohn’s disease’. J. Clinical Microbiology 24, 357–363.
Chiodini, R.J., VanKruiningen, H.J., Thayer, W.R., Merkal, R.S. and Coutu, J. (1984) ‘Possible role of mycobacteria in in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn’s disease’. Digestive Diseases and Sciences 29, 1073–1079.
Cho, S.N., Brennan, P.J., Yoshimura, H.H., Korelitz, B.I. and Graham, D.Y. (1986) Mycobacterial aetiology of Crohn’s disease: serologic study using common mycobacterial antigens and a species-specific glycolipid antigen from Mycobacterium paratuberculosis’. Gut 27, 1353–1356
Cho, S.N., Fujiwara, T., Hunter, S., Rea, T., Gelber, R. and Brennan, P.J. (1984) ‘Use of an artificial antigen containing the 3,6-di-0-methyl-beta-D-glycopyranosyl epitope for the serodiagnosis of leprosy’. J. Infectious Diseases 150, 311–322.
Colement, L., Pattyn, S. and Michielsen, P. (1988) ‘Acid-fast bacilli in Crohn’s disease’. Lancet 1, 294–295.
Coloe, P., Wilke, C, Lightfoot, D. and Tosolini, F. (1986) ‘Isolation of a Mycobacterium species resembling M. para-tuberculosis from the bowel dissue of a patient with Crohn’s disease. Australian J. Microbiology 7, 188.
Crohn, B., Ginzburg, L. and Oppenheimer, G. (1932) ‘Regional enteritis—a pathologic and clinical entity. J. American Medical Association 99, 1323–1329.
Dalziel, T.K. (1913) ‘Chronic intestinal enteritis’. British Medical Journal 2, 1068–1070.
Das, P. and Shukla, H. (1975) ‘Abdominal tuberculosis demonstration of tubercle bacilli in tissues and experimental production of hyperplastic enteric lesions. British J. Surgery 62, 610–617.
Elliott, P., Burnham, W., Berghouse, L., Lennard-Jones, J. and Langman, M. (1982) ‘Sulphadoxine-pyrimethamine therapy in Crohn’s disease. Digestion 23, 132–134.
Elliott, P., Lennard-Jones, J., Burnham, J., White, S. and Stanford, J. (1980) ‘Further testing with mycobacterial antigens in inflammatory bowel disease’. Lancet 2, 483–484.
Fletcher, J. and Hinton, J. (1967) ‘Tuberculin sensitivity in Crohn’s disease. A controlled study’. Lancet 2, 753–754.
Gitnick G., Collins, J., Beaman, B., Brooks, D., Arthur, M., Imaeda, T. and Palieschesky, M. (1989) ‘Preliminary report on isolation of mycobacteria from patients with Crohn’s disease’. Digestive Diseases and Sciences 34, 925–932.
Graham, D.Y., Markesich, D.C. and Yoshimura, H.H. (1987) ‘Mycobacteria and inflammatory bowel disease. Results of culture’. Gastroenterology 92, 436–442.
Grange, J.M., Gibson, J., Nassau, E, and Kardjito, T. (1980) ‘Enzyme-linked immunosorbent assay (ELISA): a study of antibodies to Mycobacterium tuberculosis in the IgG, IgA, and IgM classes in tuberculosis, sarcoidosis and Crohn’s dsease’. Tubercle 61, 145–152.
Haga, Y. (1986) ‘Mycobacteria in Crohn’s disease’. Japanese J of Gastroenterology 93, 2325–2333.
Haga, Y, Funakoshi, I., Nakajima, H., Sano, M., Murata, A., Munakata, A. and Kuroe, K. (1986) ‘Antibodies to Mycobacterium paratuberculosis in sera of patients with Crohn’s disease’. Digestive Organ and Immunology (Japan) 17, 100–103.
Hampson, S., Parker, M., Saverymutter, S., McFadden, J. and Hermon-Taylor, J. (1988) ‘Results of quadruple antimyco-bacterial chemotherapy in 17 Crohn’s disease patients completing six months treatment’. Gastroenterology 94, 170.
Hawley, P.R. (1975) ‘Experimental intestinal granulomas’. Proc. Royal Society of Medicine 68, 34.
Howell-Jones, J. and Lennard-Jones, J. (1966) ‘Corticosteroids and corticotrophin in the treatment of Crohn’s disease’. Gut 7, 181–187,.
Jiwa, N., Mulder, C., and van den Berg, F. (1989) ‘Elevated IgG serum levels to mycobacterial PPD in Crohn’s disease’. Netherland J. Medicine 32, (in press).
Johnson, L., Wirostko, E. and Wirostko, W. (1989) ‘Crohn’s disease uveitis. Parasitization of vitreous leukocytes by mollicute-like organisms’. Am. J. Clin. Pathol. 91, 259–264.
Kobayashi, K., Brown, W.R. and Brennan, P.J. (1988) ‘Serum antibodies to mycobacterial antigens in active Crohn’s disease’. Gastroenterology 94, 1404–1411.
Kobayashi, K., Blaser, M.J. and Brown, W.R. (1989) ‘Immuno-histochemical examination for mycobacteria in intestinal tissue from patients with Crohn’s disease’. Gastroenterology 96, 1009–1015.
Maltman, L. (1974) ‘Immunology’ In: Cell Wall Deficient Forms. CRC Press, Boca Raton, FL pp. 139–141.
Matthews, N., Mayberry, J. and Rhodes, J. (1980) ‘Agglutinins to bacteria in Crohn’s disease. Gut 21, 376–380.
McClure, H., Chiodini, R., Anderson, D., Swenson, R., Thayer, W.R. and Coutu, J. (1987) ‘Mycobacterium paratuberculosis infection in a colony of stumptail macaques (Macaca arctoides)’. J. Infectious Diseases 155, 1011–1019.
McFadden, J.J., Butcher, P.D., Chiodini, R.J. and Hermon-Taylor, J. (1987) ‘Determination of genome size and DNA homology between an unclassified Mycobacterium species isolated from patients with Crohn’s disease and other mycobacteria’. J. General Microbiology 133, 211–214.
McFadden, J.J., Butcher, P.D., Chiodini, R.J. and Hermon-Taylor, J. (1987) ‘Crohn’s disease isolated mycobacteria are identical to Mycobacterium paratuberculosis, as determined by DNA probes that distinguish between mycobacterial species’. J. Clinical Microbiology 25, 796–801.
McFadden, J.J., Thompson, J. and Green, E. (1988) ‘Identification and characterization of further bacteria isolated from Crohn’s disease and control tissue’. Gastroenterology 94, A294.
Morganroth, J. and Watson, D.W. (1970) ‘Sensitivity to atypical mycobacterial antigens in patients with Crohn’s disease’. American J. Digestive Diseases 15, 653–657.
Murray, C. and Thomson, A. (1988) ‘Marital idiopathic inflammatory bowel disease. Crohn’s disease in a husband and wife’. J. Clinical Gastroenterology 10, 95–97.
Paris, J., Paris, J.C. and Simon, V. (1975) ‘Etude critique des effets de la médication antituberculeuse dans une série de 18 cas de formes sévères de maladie de Crohn’. Lille Medicine 20, 333–341.
Paris, J., Paris, J.C., Claerbout, J., Duval, G. and Ligand, J. (1978) ‘Résultats à distance du traitement de la Maladie de Crohn par la médication antituberculeuse’. Lille Medicine 23, 494–496.
Picciotto, A., Gesu, G.P., Schito, G.C., Tests, R., Varagona, G. and Celle, G. (1988) ‘Antimycobacterial chemotherapy in two cases of inflammatory bowel disease’. Lancet 1, 536–537.
Prantera, C., Argentieri, R., Mangiarotti, R. and Levenstein, S. (1988) ‘Antimycobacterial chemotherapy in two cases of inflammatory bowel disease’. Lancet 1, 536–537.
Reilly, R.P. and Robinson, T.J. (1986) ‘Crohn’s disease…is there a long latent period’? Postgraduate Medical J. 62, 353–354.
Schultz, M., Rieder, H., Hersh, T. and Riepe, S. (1987) ‘Remission of Crohn’s disease with antimycobacterial chemotherapy’. Lancet 2, 1391–1392.
Schulze, K., Warner, H. and Murray, D. (1977) ‘Intestinal tuberculosis: experience at a Canadian teaching institution’. Amer. J. Medicine 63, 735–745.
Shaffer, J., Hughes, S., Linaker, B., Baker, R. and Turnberg, L. (1984) ‘Controlled trial of rifampicin and ethambutol in Crohn’s disease’. Gut 25, 203–205.
Stanford, J. (1981) ‘Acid fast organisms in Crohn’s disease and ulcerative colitis’ In: A.S. Pena, I.T. Weterman, C.C. Booth and W. Strober (eds.), Recent Advances in Crohn’s Disease. Martinus Nijhoff, The Hague pp 274–277.
Strickland, R.G., Miller, W.C., Volpicelli, N.A., Gaeke, R.F., Wilson, I.D., Kirsner, J.B. and Williams, R.C. (1977) ‘Lymphocytotoxic antibodies in patients with inflammatory bowel disease and their spouses—evidence for a transmissible agent’. Clinical Experimental Immunology 30, 188–192.
Sweany, H. (1947) ‘Streptomycin in tuberculous enteritis’. Amer. Review of Tuberculosis 56, 415–417.
Thayer, W.R., Coutu, J.A., Chiodini, R.J. and VanKruiningen, H.J. (1988) ‘Use of rifabutin and streptomycin in the therapy of Crohn’s disease’. In: R.P. MacDermott (ed.), Inflammatory Bowel Disease—Current Status and Future Approach, Elsevier Science, New York pp 565–568.
Thayer, W.R., Coutu, J.A., Chiodini, R.J., VanKruiningen, H.J. and Merkal, R. (1984) ‘The possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn’s disease’. Digestive Diseases and Sciences 29, 1080–1085.
Thayer, W.R., Fixa, B., Komarkova, O., Charland, C. and Field., C. (1978) ‘Skin test reactivity in inflammatory bowel disease in the United States and Czechoslovakia’. Digestive Diseases and Sciences 23, 337–340.
Toulet, J., Rousselet, J. and Viteau, J.M. (1979) ‘La rifampicine dans le traitement de la maladie de Crohn’. Gastroenterologie Cliniques et Biologie 3, 209–211.
Tytgat, G.N. and Mulder, C.J. (1986) ‘The aetiology of Crohn’s disease’. International J. Colonic Disease 1, 188–192.
VanKruiningen, H.J., Chiodini, R.J., Thayer, W.R., Coutu, J.A., Merkal, R.S. and Runnels, P.L. (1986) ‘Experimental disease in infant goats induced by a Mycobacterium isolated from a patient with Crohn’s disease. A preliminary report’. Digestive Diseases and Sciences 31, 1351–1360.
VanKruiningen, H.J., Thayer, W.R., Chiodini, R.J., Menton, D. and Coutu, J.A. (1988) ‘An immunoperoxidase search for mycobacteria in Crohn’s disease’. In: R.P. MacDermott (ed.) Inflammatory Bowel Disease. Current Status and Future Approach Elsevier Science, New York pp. 547–552.
Warren, J., Rees, H. and Cox, T. (1986) ‘Remission of Crohn’s disease with tuberculosis chemotherapy’. New England J. Medicine 314, 182.
Watson, D.W. and Martucci, R. (1974) ‘Sensitivity to mycobacterial antigens in patients with Crohn’s disease’. Gastroenterology 66, 794.
White, S. (1981) ‘Investigations into the identity of acid fast organisms isolated from Crohn’s disease and ulcerative colitis’. In: A.S. Pena, I.T. Weterman, C.C. Booth and W. Strober (eds.), Recent Advances in Crohn’s Disease, Martinus Nijhoff, The Hague pp 274–277.
Whorwell, P.J., Davidson, I.W., Beeken, W.L. and Wright, R. (1978) ‘Search by immunofluorescence for antigens of rota virus, Pseudomonas maltophilia, and Mycobacterium kansasii in Crohn’s disease’. Lancet 2, 697–698.
Williams, W. (1965) ‘A study of Crohn’s syndrome using tissue extracts and the Kveim and Mantoux tests’. Gut 6, 503–505.
Wirostko, E., Johnson, L. and Wirostko, B. (1987) ‘Crohn’s disease. Rifampin treatment of the occular and gut disease’. Hepatogastroenterologie 34, 90–93.
Yoshimura, H.H., Graham, D.Y., Estes, M.K. and Merkal, R.S. (1987) ‘Investigation of association of mycobacteria with inflammatory bowel disease by nucleic acid hybridization’. J. Clinical Microbiology 25, 45–51.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Thayer, W.R. (1990). Are Mycobacteria the Cause of Crohn’s Disease?. In: Rachmilewitz, D., Zimmerman, J. (eds) Inflammatory Bowel Diseases 1990. Developments in Gastroenterology, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1980-8_5
Download citation
DOI: https://doi.org/10.1007/978-94-009-1980-8_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7385-1
Online ISBN: 978-94-009-1980-8
eBook Packages: Springer Book Archive